市場調查報告書
商品編碼
1447713
遠距患者監護市場:按產品、應用和最終用戶劃分——到 2031 年的全球預測Remote Patient Monitoring Market by Product, Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031 |
預計到 2031 年,全球遠距病患監護市場將達到 1,168.4 億美元,2024 年至 2031 年的複合年增長率為 13.7%。
該報告基於全面的一手和二手研究以及對市場情景的詳細分析,提供了該行業的關鍵驅動因素、限制因素、挑戰和機會。 該市場的推動因素包括老年人口不斷增長、慢性病患病率上升、醫療保健專業人員短缺、人們越來越認識到RPM 的好處(例如便利性和改善患者治療效果)以及降低醫療成本的需求不斷增長。驅動因素包括政府的有利措施促進遠距患者監護。
此外,遠距醫療和遠距患者監護方面的技術進步、新興國家患者數量的增加、可穿戴設備的日益普及、感測器技術的進步以及人工智慧和RPM 的整合正在推動該市場的顯著增長。我們提供機會。 然而,對數據準確性和可靠性的擔憂、限制遠端患者監測技術使用的障礙(例如存取限制)以及患者技術素養較低正在限制市場成長。 此外,對資料安全和隱私的擔憂,以及由於需要額外的人員來管理 RPM 系統而增加的管理成本,都對市場構成了挑戰。
以產品來看,預計到2024年,監護設備領域將佔據遠距病患監護市場的最大份額。 此細分市場的重要份額是由於各種慢性病的盛行率不斷上升、老年人口不斷增加、有利的監管環境、感測器技術的技術進步、個人化醫療保健的需求不斷增長、監測設備的人為增長。這是由於以下因素智能與機器學習的融合。
從應用來看,糖尿病領域預計將在 2024 年佔據遠端患者監測市場的最大份額。 傳統上,糖尿病主要被認為是一種遺傳性疾病,但其迅速流行使其被認為是一種與生活方式相關的疾病。 這個細分市場的很大一部分是由於遠距醫療在糖尿病管理中的使用、糖尿病盛行率的增加以及監測糖尿病患者的需求增加等因素造成的。
從最終用戶來看,家庭醫療保健領域預計將在 2024 年佔據遠距患者監護市場的最大份額。 該細分市場的巨大市場份額是由家庭護理環境的日益轉變、老年人慢性病發病率的增加、醫療專業人員的短缺以及消費者對使用RPM工具監測慢性病的意識不斷增強等推動的。
對全球遠距病患監護市場區域狀況的詳細分析提供了五個關鍵區域的詳細定性和定量見解。 到2024年,預計北美將佔據全球遠距病患監護市場的最大份額,其次是歐洲、亞太地區、拉丁美洲以及中東和非洲。 亞太地區預計將成為全球遠距患者監護市場成長最快的地區。 這一增長主要是由醫療保健支出增加、老年人口不斷增長、慢性病患病率上升、消費者意識提高、個人可支配收入增加以及更大的目標人群推動的,從而支持了市場成長。
Remote Patient Monitoring Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight Monitoring] [Wearable, Portable, Benchtop]), Application (Diabetes, Oncology, Cardiovascular, Neurological Disorders), End User-Global Forecast to 2031
The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the increasing geriatric population, rising prevalence of chronic diseases, shortage of healthcare professionals, growing awareness regarding the benefits of RPM, such as convenience and improved patient outcomes, rising need to reduce healthcare costs, and favorable government initiatives promoting remote patient monitoring.
Furthermore, technological advancements in telehealth & remote patient monitoring, emerging economies with growing patient populations, increasing adoption of wearable devices, advancements in sensor technologies, and integration of artificial intelligence with RPM provide a significant growth opportunity for this market. However, data accuracy & reliability concerns, barriers limiting the use of remote patient monitoring technologies such as limited access, and low technology literacy among patients restrain the growth of the market. Additionally, data security & privacy concerns and increased overhead expenses due to the need for additional staff to manage the RPM system are challenging factors in the market.
Among products, in 2024, the monitoring devices segment is expected to account for the largest share of the remote patient monitoring market. The large share of this segment is attributed to factors such as the increasing prevalence of various chronic diseases, the rising elderly population, favorable regulatory scenarios, technological advancements in sensor technology, the rising demand for personalized healthcare, and the integration of artificial intelligence and machine learning in monitoring devices.
Among applications, in 2024, the diabetes segment is expected to account for the largest share of the remote patient monitoring market. Diabetes was traditionally viewed as a predominantly inherited disease but is increasingly recognized as a lifestyle-related condition due to its rapid prevalence. The large share of the segment is due to factors such as the utilization of telehealth during diabetes management, the increasing prevalence of diabetes, and the increased need to monitor diabetic patients.
Among end users, in 2024, the home-care settings segment is expected to account for the largest share of the remote patient monitoring market. This segment's large market share is attributed to the growing shift towards home-care settings, the rise in chronic diseases among the elderly, the shortage of healthcare professionals, and increasing consumer awareness regarding the monitoring of chronic conditions through RPM tools.
An in-depth analysis of the geographical scenario of the global remote patient monitoring market provides detailed qualitative and quantitative insights for the five major geographies: North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global remote patient monitoring market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global remote patient monitoring market. This growth is primarily driven by the increasing healthcare expenditure, rising geriatric population, rising prevalence of chronic diseases, growing consumer awareness, increasing personal disposable incomes, and a large target population, thereby supporting the market growth.
The key players operating in the global remote patient monitoring market are Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and VitalConnect, Inc. (U.S.).
Remote Patient Monitoring Market Assessment-by Product
Note: Other monitoring devices include temperature monitors, brain monitoring (EEG), and prothrombin monitors.
Remote Patient Monitoring Market Assessment-by Application
Note: Other applications include maternity care, post-surgery monitoring, elderly care, medical adherence, and sleep monitoring.
Remote Patient Monitoring Market Assessment-by End User
Note: Other end users include ambulatory care, healthcare payers, and clinical research organizations
Remote Patient Monitoring Market Assessment-by Geography